DGCI approved drug trial of phytopharmaceutical, favipiravir to treat COVID-19 patient
With this approval, CSIR will begin the clinical trial of two drugs to treat COVID-19 patients. The drug trial will begin soon.
Free Current Affairs to Your Email
|